AOP Orphan hosted an experts press conference at the annual meeting of the German, Austrian and Swiss societies for haematology and medical oncology DGHO in Berlin on Friday, October 11, 2019.
To download the press release please sign in in the protected area on a country level, e.g. via Austrian or German website.
The press release is solely for healthcare professionals, medical writers or specialized medical journalists.
About AOP Orphan Pharmaceuticals AG:
AOP Orphan is a multinational company with headquarters in Vienna, Austria focusing on clinical development, marketing and distribution of medicines for rare and complex diseases. AOP Orphan provides innovative treatment options, further individualized and customized services to meet physicians and patients needs across Europe, the Middle East & Asia. Currently, AOP Orphan is specializing in therapeutic solutions for HematoOncology, Cardiology & Pulmonology and Neurology & Metabolic Disorders.
To stay updated, follow AOP Orphan on LinkedIn: https://www.linkedin.com/company/aop-orphan-pharmaceuticals/
AOP Orphan Pharmaceuticals AG
Wilhelminenstrasse 91/IIf, 1160 Vienna, Austria